MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s share price traded up 7.1% on Thursday . The company traded as high as C$0.08 and last traded at C$0.08. 569,150 shares changed hands during trading, an increase of 51% from the average session volume of 376,264 shares. The stock had previously closed at C$0.07.
MediPharm Labs Stock Up 14.3 %
The company’s 50 day simple moving average is C$0.07 and its 200-day simple moving average is C$0.07. The company has a debt-to-equity ratio of 1.45, a quick ratio of 3.10 and a current ratio of 3.21. The firm has a market capitalization of C$33.20 million, a PE ratio of -2.76 and a beta of 0.88.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Featured Articles
- Five stocks we like better than MediPharm Labs
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Golden Cross Stocks: Pattern, Examples and Charts
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- 3 Stocks to Consider Buying in October
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
